Treato Launches Social Media Application for an Expanded View of the Patient Pulse

NEW YORK, June 23, 2015 /PRNewswire/ --

Today Treato, the leading source for consumer healthcare insights, announces the launch of their new Social Media Application.  The latest application will apply Treato's advanced big data infrastructure to broad social sentiment for a top line view into today's health consumer, expanding Treato's offering of patient intelligence tools to provide healthcare companies with an end-to-end solution. The application will allow business customers to understand the social media landscape with views into social trends, gauge real-time social sentiment, identify favored networks, and gain viral reach and insights into their competitors' brands.   

Treato has built its industry expertise by turning online patient experiences into deep business intelligence for the health and life sciences industries.  The company's unique advanced algorithms and patient health analytics, that top pharma companies have come to depend on, turn billions of conversations into tangible business insights.  Now, that very same expertise has been applied to tracking the social conversation trajectory and velocity with sentiment analysis.

"Customers have come to rely on us for our deep understanding of patient conversations happening online," says Ido Hadari, CEO of Treato.  "With the addition of our Social Media Application we take what we do best -  unique big data analytics  - and apply it to, not only health consumers' personal experiences but to broad social sentiment allowing pharma customers to better understand their health space and engage their customers."

Treato will be offering pharmaceutical companies a complimentary trial of the Social Media Application.  Click here to learn more.

About Treato: 

Treato™, the leading source of real health insights from millions of real health consumers, uses patented analytics and big data technology to turn billions of disparate online conversations into meaningful social intelligence.  With 2 billion posts analyzed and continuously expanding, Treato has partnered with 13 of the top 50 pharmaceutical companies and its consumer website helps millions of visitors each month.

Treato is privately held with offices in Israel, New York and Princeton, NJ. Investors include Reed Elsevier Ventures, OrbiMed Partners and New Leaf Venture Partners, among others. For more information please visit http://treato.com and corp.treato.com.

Supporting Resources:

▪  Learn more on the Treato blog

▪  Like Treato on Facebook

▪  Follow Treato on LinkedIn

▪  Follow Treato on Twitter: @Treato_com

Contact: Allyson Noonan, [email protected] , +1-858-245-7256

SOURCE Treato